Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial (Q30883545)

20 August 2017

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial (English)

1 reference

20 August 2017

phase II clinical trial

0 references

0 references

1 reference

PubMed publication ID

27 June 2017

Ivo N van Schaik

1 reference

20 August 2017

Marianne de Visser

1 reference

20 August 2017

Camiel Verhamme

1 reference

20 August 2017

Rob J de Haan

series ordinal

1 reference

20 August 2017

Marinus Vermeulen

series ordinal

1 reference

20 August 2017

language of work or name

English

0 references

publication date

12 November 2009

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

Ascorbic acid inhibits PMP22 expression by reducing cAMP levels.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Statistics notes: Analysing controlled trials with baseline and follow up measurements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Hand-held myometry: reference values

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

PMP22 overexpression causes dysmyelination in mice.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-7-70

Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-7-70

Reliability and validity of the CMT neuropathy score as a measure of disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-7-70

The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-7-70

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-7-70

Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-7-70

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784478

Motor unit number estimation using high-density surface electromyography

25 November 2018

1 reference

12 December 2020

Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication

1 reference

12 December 2020

Vitamin C allergy of the delayed type

1 reference

12 December 2020

Endogenous ascorbic acid synthesis and recommended dietary allowances for vitamin C

1 reference

12 December 2020

Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I)

1 reference

12 December 2020

Influence of recording site on CMAP amplitude on its variation over a length of nerve

1 reference

12 December 2020

Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy

1 reference

12 December 2020

Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy

1 reference

12 December 2020

Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice

1 reference

12 December 2020

Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study

1 reference

12 December 2020

Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia

1 reference

12 December 2020

136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands

1 reference

12 December 2020

Neuropathy progression in Charcot-Marie-Tooth disease type 1A

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-7-70

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference

20 August 2017

PubMed publication ID

19909499

1 reference